Viewing Study NCT00105235


Ignite Creation Date: 2025-12-24 @ 10:16 PM
Ignite Modification Date: 2025-12-29 @ 9:45 PM
Study NCT ID: NCT00105235
Status: COMPLETED
Last Update Posted: 2012-12-27
First Post: 2005-03-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: DAIT ITN024ST
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View